All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Effects of polyphenol compounds melanin on NAFLD/NASH prevention

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62157124%3A16370%2F17%3A43876014" target="_blank" >RIV/62157124:16370/17:43876014 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216224:14110/17:00098633

  • Result on the web

    <a href="http://dx.doi.org/10.1016/j.biopha.2017.01.028" target="_blank" >http://dx.doi.org/10.1016/j.biopha.2017.01.028</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.biopha.2017.01.028" target="_blank" >10.1016/j.biopha.2017.01.028</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Effects of polyphenol compounds melanin on NAFLD/NASH prevention

  • Original language description

    Background: One of the pathogenic mechanisms of the progression non-alcoholic liver disease ( NAFLD) to nonalcoholic steatohepatitis (NASH) is the accumulation of reactive oxygen species (ROS). So, antioxidant therapy is necessary for successful treatment of the liver injury. We have paid attention to melanin produced by yeast Nadsoniella nigra strain X-1 as novel antioxidant and anti-inflammatory agents with low toxicity. In current study we aimed to investigate the preventive effect of melanin on the monosodium glutamate (MSG) induced NAFLD model in rats. Methods: The study was carried out on 45 Wistar rats that were divided into 3 groups: intact, MSG-and MSG + melanin groups (n = 15 in each group). Newborn rats of MSG-and MSG + melanin groups were administered with MSG (4 mg/g, 8 mu l/g, subcutaneously) at 2nd-10th days of life. Since the age of 1 month, rats of MSG-group were treated with water (0.25 ml/100 g), rats of MSG + melanin groups-with melanin (1 mg/kg) dissolved in water (0.25 ml/100 g). Introduction: had been performed intermittently (two-week courses alternated with two-week breaks) for 3 months. In 4-month rats anthropometrical parameters and visceral adipose tissue (VAT) mass were estimated. To assess morphological changes in liver we used NAS (NAFLD activity score). The content of pro-inflammatory cytokines (interleukin (IL)-1 beta, IL-12Bp40, interferon (INF)-gamma) and anti-inflammatory cytokines (IL-4, IL-10, tumor growth factor (TGF)-beta) were measured by ELISA. Results: We found significantly lower total score (1.0 +/- 0.19 vs 3.33 +/- 0.36, p &lt; 0.001), degree of steatosis (0.73 +/- 0.18 vs 1.80 +/- 0.17, p &lt; 0.001) and manifestation of lobular inflammation (0.27 +/- 0.11 vs 1.20 +/- 0.17, p &lt; 0.001) due to NAFLD activity score in MSG + melanin group compared to MSG-obesity. NASH we confirmed only in 33.3% of rats with MSG-obesity that was significantly higher than after melanin (6.7%) administration (p = 0.033). Melanin administration reduce amount of visceral fat on 44.5% (p 0.001) as compared to MSG-obesity group. Melanin reduced the content of IL-1 beta in rat serum and restored the level of anti-inflammatory cytokines (IL-10, TGF-beta) to the control values. Conclusion: Thus, the administration of melanin can prevent development of NAFLD/NASH in rats with MSG-induced obesity and can be considered as possible novel therapeutic agents but further studies to confirm its action needed.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30104 - Pharmacology and pharmacy

Result continuities

  • Project

  • Continuities

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Biomedicine &amp; pharmacotherapy

  • ISSN

    0753-3322

  • e-ISSN

  • Volume of the periodical

    88

  • Issue of the periodical within the volume

    APR 2017

  • Country of publishing house

    FR - FRANCE

  • Number of pages

    10

  • Pages from-to

    267-276

  • UT code for WoS article

    000395528000031

  • EID of the result in the Scopus database